{"schema_version":"secwatch.filing_event.v1","accession":"0001297184-25-000036","form_type":"8-K","ticker":"AMPH","cik":"0001297184","company_name":"Amphastar Pharmaceuticals, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.859499+00:00","generated_at":"2026-05-19T23:41:50.069939+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Stockholders approve charter amendments for officer exculpation and forum selection removal at annual meeting","bullets":["Elected three Class III directors: Jack Y. Zhang, Richard Prins, Diane G. Gerst (each with majority support).","Approved charter amendment for officer exculpation under Delaware law (35.5M for, 2.9M against).","Approved removal of forum selection provision from charter (37.4M for, 52k against).","Ratified Ernst & Young as independent auditor for fiscal 2025 (41.5M for).","Bylaws amended to specify Delaware Court of Chancery as exclusive forum for certain internal actions."],"urls":{"canonical":"https://secwatch.observer/filing/0001297184-25-000036","json":"https://secwatch.observer/filing/0001297184-25-000036.json","markdown":"https://secwatch.observer/filing/0001297184-25-000036.md","text":"https://secwatch.observer/filing/0001297184-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/0001297184-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/amph-20250602x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:41:50.069939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"065cb9ada093ebe1f4340e39e4e4e8e0d328a3a7","claim":"Amphastar Pharmaceuticals, Inc.: Approved amendment to Bylaws to clarify exclusive forum selection for certain legal actions (effective 2025-06-02).","evidence_excerpt":"the board of directors of the Company approved an amendment to the amended and restated bylaws of the Company (the “Bylaws” and such amendment, the \"Bylaws Amendment”) clarifying that unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the United States District Court for the District of Delaware) and any appellate court therefrom will be the sole and exclusive forum","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/0001297184-25-000036-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-06-02"}],"fact_type":"governance_change"},{"claim_id":"a1b072338f38b137e0b617cf05598d55d71fc177","claim":"Amphastar Pharmaceuticals, Inc.: Approved amendment to Charter to include officer exculpation provisions under Delaware law (effective 2025-06-02).","evidence_excerpt":"the stockholders of the Company voted on and approved amendments to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) (i) to reflect Delaware law provisions regarding officer exculpation (the “Exculpation Amendment”);","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/0001297184-25-000036-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-02"}],"fact_type":"governance_change"},{"claim_id":"bf42be41dc62024e161d6a5ec90407842d5cdd66","claim":"Amphastar Pharmaceuticals, Inc.: Approved amendment to Charter to remove forum selection provision (effective 2025-06-02).","evidence_excerpt":"and (ii) to remove the forum selection provision (the “Forum Selection Amendment,” and together with the Exculpation Amendment, the “Charter Amendments”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/0001297184-25-000036-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}